153. Acute encephalitis with refractory, repetitive partial seizures Disease details / Clinical trials / Drug dev / DR info /


Clinical trial : 1 Drug : 1 - (DrugBank : 1) / Drug target gene : 1 - Drug target pathways : 11

Drugs, Primary sponsors and Trial info (Enrollment year, Phase, Trial ID, Countries)
Tocilizumab
   Peking University First Hospital
      2024   Phase 4   ChiCTR2400085185   China